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HOW SAFE IS OUR FOOD?











 In the not-so-distant past, most
food was produced and consumed locally. In the 20th
century, however, the production and distribution of
food in the developed countries of the world have be-
come increasingly industrialized. Small farms are being
replaced by feedlots, local dairies supplanted by indus-
trial plants, farmers’ markets displaced by supermar-
kets, and local restaurants edged out by huge national
chains. The relations among agricultural workers, food
processors, and distributors have become increasingly
complex and distant. The food chain and steps in food
production are being varied in ways that stretch the
imagination. From an economic standpoint, modern
agribusiness offers many benefits, including the wide
choices and apparently low costs of food available to
the consumer. The development of national standards
has improved food safety, yet certain microbial patho-
gens persist, the scale of foodborne transmission is in-
creasing, and new hazards are being recognized. Many




 in the clear and comprehensive report by Hen-






Salmonellosis — with the notable exception of ty-
phoid fever — is a disease of civilization. The animals
we use for food production frequently carry salmonella,




Salmonellosis is rare in developing countries, where
sanitation is poor and diarrheal diseases are endemic,




In contrast, in the United States the reported incidence





 and approximately 1 percent of the population




 Outbreaks are becoming
larger and, as shown by Hennessy and coworkers, may
affect hundreds of thousands of people.
Most cases of salmonellosis (and foodborne illness)
are considered to be endemic (or sporadic) because they
are not clustered. The usual explanation for endemic
cases is the inappropriate handling in kitchens and res-
taurants of contaminated food (including improper
storage, undercooking, or cross-contamination). This is
a plausible hypothesis because so many of the farm an-
imals in the United States are colonized with salmo-
nella and products derived from these animals subse-
quently become contaminated. Alternatively, sporadic
cases of disease may occur when a widely distributed
food has low levels of contamination, a situation that
leads to a low attack rate diffusely distributed over a
large geographic area, so that no one realizes that an





 illustrates this second pattern. Despite
substantial publicity, fewer than 600 of the more than
200,000 estimated cases of salmonellosis in this out-
break (only 0.3 percent) were actually reported to pub-
lic health departments. The epidemic both highlights





 and illustrates the value of
field epidemiology that uses current surveillance data
to detect outbreaks and prevent further transmission
and disease. The cooperation of state and federal agen-
cies and the speed with which they worked to solve the
puzzle and protect the public safety make this a model
for future investigations.
However, this epidemic probably reflects only the tip
of the iceberg. The low surveillance rate suggests that
smaller outbreaks are regularly missed. That the inci-
dence of salmonellosis among persons with AIDS is




 is also con-
sistent with the view that widely distributed foods are
contaminated by low doses of a pathogenic agent, lead-





 Such sentinel populations teach
us much about the distribution of particular agents.
This model also may be applicable to other foodborne
illnesses, in which detection of the agent and surveil-
lance are even less efficient than for salmonella. The




 infections in per-




points to the widespread transmission of low levels of
this foodborne agent as well.
Modern food production is often so complex that
many points at which contamination could occur are
simply not recognized. Thus, in the outbreak of sal-
monellosis the use of tanker trailers to ship both pas-
teurized and nonpasteurized products represents a clas-
sic cross-connection that was not identified until the
investigation was undertaken. The bulk transport of
nonpasteurized liquid eggs provides an efficient means





 so that it affects large numbers
of consumers. This outbreak underscores the fact that
to minimize risk from unrecognized hazards, pasteuri-
zation — one of the most powerful tools against bacte-
rial pathogens in the public health armamentarium —
should be undertaken at the latest possible step in food
production.
Manifestations of foodborne disease are not restrict-
ed to the gastrointestinal tract, as illustrated by the


























nor are the ramifications always obvious. The most
pernicious threat may be the spread of antibiotic resist-




 because of the promis-
cuous use of subtherapeutic doses of antibiotics as food
supplements for farm animals, or the potential food-
borne spread of the scrapie agent. New opportunities
for foodborne diseases result from the increasing inter-
nationalization of our food supply, with the importation
of foodstuffs from all parts of the globe, the introduc-
tion of new and sometimes uncooked items into our
diets, and the preparation of food in restaurants and






Food is not sterile, and eating cannot be made risk-
free. Because of the standardization and quality-control
measures that are part of industrialized food produc-
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tion, the safety of our food from many microbial haz-
ards has probably never been greater. Yet because of
the potential for amplification of a pathogen that is
implicit in large-scale food production, the opportuni-
ties for the foodborne transmission of disease seem to
be increasing. The grim implications of bovine spongi-
form encephalopathy (mad-cow disease) for cattle and
possibly humans point to the unanticipated problems
that can arise from a breach in basic ecologic relations
(cows, which are herbivores, were fed animal offal).
Since new hazards are emerging from both familiar
pathogens such as salmonella and previously unrecog-
nized microbial threats, improved surveillance for food-
borne infections is essential. Careful medical detective





highlight the basic ecologic imbalances underlying en-
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 physical activity is important for health





 Nonetheless, fewer than half of Amer-




 A recent federal





on three major considerations: the potential health ben-
efits, safety, and feasibility of different amounts and in-
tensities of physical activity. This recommendation ap-
plies to both men and women, but safety is particularly
relevant to women, since exercise of high intensity and
long duration may lead to menstrual and reproductive
dysfunction. Given the potential differences between
men and women in the balance of the benefits and the
risks of exercise, what should the optimal guidelines be
regarding physical activity for women?
The recent recommendations regarding exercise from
the Centers for Disease Control and Prevention and
the American College of Sports Medicine encourage 30
minutes of moderately intense physical activity on most,




 This contrasts with
previous recommendations that generally endorsed vig-
orous endurance exercise (i.e., at a level that results in
a heart rate 60 to 90 percent of the maximal rate) for




 The earlier rec-
ommendations were based on physiologic data showing
that such a regimen induced cardiorespiratory fitness in
untrained or previously sedentary people. The recent
and less formidable recommendation was designed, in
part, to present less of an obstacle to exercise in the
predominantly sedentary U.S. population. Unfortunate-
ly, many have interpreted the new recommendation as
superseding previous guidelines and as meaning that
high-intensity exercise offers no additional benefit over
physical activity of moderate intensity. This is a misin-
terpretation. In fact, the recent guidelines state that
“the recommendation presented . . . is intended to
complement, not supersede, previous exercise recom-
mendations,” and “people who already meet the recom-
mendation are also likely to derive some additional
health and fitness benefits from becoming more physi-
cally active.” 









dence supporting the latter statement by documenting
a dose–response relation for plasma high-density lipo-
protein (HDL) cholesterol concentrations among wom-
en runners. HDL cholesterol levels increased with in-
creasing numbers of kilometers run, even beyond 64
km per week. Should we then recommend a maximal
intensity and amount of physical activity for women?
Before we reach this conclusion, the issues of efficacy,
safety, and feasibility must be carefully weighed.
The available data indicate that physical activity is
associated with numerous benefits in terms of health,
including a lower incidence of cardiovascular disease,
non-insulin-dependent diabetes mellitus, osteoporotic





ular physical activity also helps to maintain a healthy
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On the other hand, if extreme loss of weight and





 Sustained alterations in the levels of female re-





 In female athletes who increase their
running mileage, levels of progesterone in the midluteal
phase are lower during the cycles in which mileage is
increased; in addition, the luteal phase may be short-
ened, with or without prolongation of the follicular
phase. If the hormonal dysfunction progresses, anovu-
lation may follow, initially in the presence of normal
estrogen levels; later, hypoestrogenic amenorrhea may
occur. Infertility is also more likely to occur among





 Because of the integral role of
estrogen in maintaining bone mass, osteoporosis is an-




Female athletes with amenorrhea have lower bone min-
eral density than their counterparts with normal men-
strual patterns who follow the same exercise regimens.
When female athletes resume normal menses, they re-
gain some bone mass, but bone density may still be
lower than in athletes who have continued to have nor-
mal menses. In addition to amenorrhea and osteoporo-
sis, eating disorders (including anorexia nervosa and
bulimia nervosa) may occur, especially among adoles-
cent and young adult female athletes involved in activ-
ities in which thinness is perceived to have aesthetic





tion of medical disorders, termed the “female-athlete
triad,” has been an increasing source of concern to ex-
perts in sports medicine.
With high intensities and large amounts of physical
activity, musculoskeletal injuries are another potential
mechanism of adverse effects on health. The available
data regarding injuries associated with different types
of physical activity are limited. Running has been stud-
ied the most; the risk appears to be fairly substantial,




There also appears to be a direct relation between the
risk of musculoskeletal injury and the distance run per
week. Moreover, in those who have habitually been sed-
entary, the initiation of vigorous exercise may substan-
tially increase the risk of acute myocardial infarction;





The study by Williams does not allow us to evaluate
the balance of benefits and risks of higher amounts and
intensities of physical activity. Specifically, it does not
provide information on the prevalence of menstrual ir-
regularities (we know only the percentage of the wom-
en who reported still having periods), bone mineral
density, or the frequency of musculoskeletal injuries. It
would have been helpful to examine whether these ad-
verse health effects increase in frequency with increas-
ing distance run per week.
Evidence from other sources indicates, however, that
the risks of reproductive and musculoskeletal problems
associated with high-intensity physical activity exceed
those associated with moderate physical activity; thus,
it is of particular importance to compare the relative
benefits of high-intensity and moderate-intensity exer-
cise. The data that are available demonstrate that a
moderate amount of physical activity at a moderate in-
tensity confers important health benefits. In a study of
more than 3000 women 20 years of age or older who
were followed for eight years, Blair et al. reported an





 The greatest reduction in mortality oc-
curred between the lowest and the second-lowest quin-
tiles of the group in terms of physical fitness. As com-
pared with women in the least-fit quintile, those in the
second-least-fit quintile were 48 percent less likely to
die during follow-up. With increasing levels of physical
fitness, mortality continued to decline, although the in-
cremental gains were smaller; women in the most-fit
quintile were 78 percent less likely than the least fit to
die during follow-up. Among 73,029 women in the Nurs-
es’ Health Study who were 40 to 65 years of age at base
line and were followed for four years, the level of phys-
ical activity was inversely related to the incidence of





largest reduction in risk occurred between the lowest
and the second-lowest quintiles with respect to physical
activity; even brisk walking was associated with a sub-
stantial reduction in risk.
With regard to feasibility, given the high prevalence
of sedentary lifestyles among adult Americans — some





 — it is unrealistic to expect
that this nation will cheerfully embrace an exercise reg-
imen that involves long periods of intense physical ac-
tivity, whatever the benefits in terms of health. The re-
cent recommendation that adults engage in 30 minutes
of moderately intense physical activity, such as brisk
walking, on most days of the week represents a more
feasible goal. Moreover, physical activity at moderate
intensity has fewer health risks than vigorous activity,





 We do not mean to discount the additional health
benefits that may accrue with more frequent, longer,
and more intense physical activity, and we would not
dissuade those who wish to exercise more. We do be-
lieve, however, that at some point the risks outweigh
the health benefits of increased physical activity. If
amenorrhea, reproductive disorders, or repeated mus-
culoskeletal injuries occur, we believe that the level of
exercise that produces these complications is excessive,
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 a record number of applicants to medical
schools in the United States in 1995 and concern about
a surplus of physicians, it is sometimes forgotten that
many people are underserved by the medical profes-
sion, particularly the poor, members of minority groups,
and residents of rural areas. Although the underserved
are less likely to have health insurance or other finan-
cial resources, they are more likely to have medical
needs. These needs may be aggravated by social or fi-
nancial problems, language barriers, or inability to find
high-quality care.




 Komaromy et al. docu-
ment the essential role of minority physicians in Cali-





 The findings are striking and are consistent




 At a time when col-
lege and university admissions policies that give prefer-
ence to members of minority groups are under attack
throughout the country, such data are particularly rel-
evant. In July 1995, the regents of the University of
California banned preference based on race or sex in




 In March 1996,
the U.S. Court of Appeals for the Fifth Circuit sharply





 And in November 1996, Califor-
nians will vote on the California Civil Rights Initiative,
a measure that would ban race- and sex-based prefer-
ences in public employment, public education, and pub-
lic contracting. Thus, although there is strong support
within the medical profession for increasing racial, eth-





near future fewer members of minority groups may en-
ter medical practice.
Using various sources of information and a survey of
physicians, Komaromy et al. examined the relation be-
tween the characteristics of physicians in California
and the communities where they practice. Communities
with high proportions of black and Hispanic residents
were substantially more likely than other areas to have
shortages of physicians, regardless of community in-
come. On average, black and Hispanic physicians prac-
ticed in areas with fewer primary care physicians per
capita than did white physicians. These areas tended to
have higher proportions of residents with the same ra-
cial and ethnic background as the physicians. Even af-
ter taking the proportions of such residents into ac-
count, Komaromy et al. found that black and Hispanic
physicians cared for substantially more black and His-
panic patients, respectively, than did other physicians.
Black physicians cared for more patients with Medicaid
insurance, and Hispanic physicians cared for more pa-
tients without health insurance.
These findings are supported by national data from





1993, 39.8 percent of students graduating from medical
school who were members of underrepresented minor-
ities (blacks, Mexican Americans, mainland Puerto
Ricans, and American Indians) said they planned to
practice in underserved areas, as compared with 8.9
percent of other graduates. Nearly 60 percent of mem-
bers of underrepresented minorities preparing for ca-
reers as generalists planned to locate in such areas, as
compared with less than 24 percent of other graduates
preparing for generalist careers.
Komaromy et al. cite studies showing that black and
Hispanic patients have less access to care, poorer-qual-
ity care, and worse outcomes than non-Hispanic whites.
Their findings are limited, however, by the absence of
data on case mix or the quality of care. People who
identify a nonwhite physician as their usual source of





 All other factors being equal, we do
not know whether racial and ethnic congruence be-
tween physician and patient is associated with better
care. We do know that patients sometimes prefer phy-
sicians with backgrounds similar to their own.
In recent years, more members of underrepresented
minority groups have applied to medical school, en-
tered, and graduated. In 1994, a record 2487 blacks,
Hispanics, and Native Americans (12.9 percent of all
entrants) entered allopathic and osteopathic schools,










 Between 1990 and 1994, 5 of the 10
medical schools with the highest percentage of under-
represented-minority graduates were in California — at
the University of California campuses at San Francisco,





other five were at Meharry, Morehouse, Howard, the
University of Illinois, and the University of Michigan.)







 increased minority enrollment in medi-
cal schools “is far from enough even to approach a goal
of parity with the minority population in the next 50
The New England Journal of Medicine 
Downloaded from nejm.org at BOSTON UNIVERSITY on December 7, 2021. For personal use only. No other uses without permission. 
 Copyright © 1996 Massachusetts Medical Society. All rights reserved. 
 
1328 THE NEW ENGLAND JOURNAL OF MEDICINE May 16, 1996
  
years, given the expected growth of that population.”
Indeed, non-Hispanic whites will represent a decreas-
ing percentage of the U.S. population according to cen-
sus projections, falling from 76 percent in 1990 to 72




In education, fostering diversity can be a win–win
situation, improving both the institution and the educa-
tional experience. We learn from people with different
backgrounds and beliefs. A recent federal review of af-
firmative-action programs at the University of Califor-
nia at Berkeley found that as the campus became more





 Physicians are teachers of their colleagues
and role models for future physicians. A diverse physi-
cian work force should help us attract people of all rac-
es and backgrounds who have outstanding personal
characteristics, genuine motivation to be primary care
physicians, and the skills needed to work in under-
served areas, such as fluency in a language other than
English and an understanding of the cultural and health
beliefs of diverse groups. Strong academic performance
and excellent training are essential, but they are not
ends in themselves. Nonetheless, when there are many
applicants for a limited number of spaces, any classifi-
cation system will be perceived as unfair to some.
In the 1970s, Allan Bakke, who is white, claimed that
he had been denied admission to the medical school at
the University of California at Davis because of a quota
system that reserved places in the entering class for
members of minority groups. In 1978, the Supreme
Court, in a five-to-four vote, found programs that set
aside a fixed number of places for minorities unconsti-
tutional, but said that colleges and universities could





 In 1995, however, the University of California
regents ended the consideration of race or ethnicity,




case, the Supreme Court sided with a white contractor
in Colorado who had been passed over for a federal
highway contract, despite having submitted the low bid,





 Justice Sandra Day O’Connor, writing for the
five-to-four majority, concluded that racial classifica-
tions imposed by federal, state, or local governments
“are constitutional only if they are narrowly tailored
measures that further compelling government inter-




 case, the Court of Appeals
for the Fifth Circuit, citing recent Supreme Court rul-
ings, rejected any consideration of race or ethnicity as
a factor in admission to the University of Texas law
school, “even for the wholesome purpose of correcting





though the immediate effects of this controversial deci-
sion are limited — the ruling was stayed in April pend-
ing an appeal by Texas — this or another case may lead
the Supreme Court to reconsider the role of affirmative
action in higher education.
As the debate over affirmative action continues, we
should pursue a variety of efforts to diversify the med-
ical work force and increase the number of physicians
who care for the underserved. There are ongoing initia-
tives to draw academically qualified minority applicants
to medical schools, such as magnet health-sciences high
schools, science-education partnerships between aca-





 Admissions decisions should
take into account career plans, interest in primary care,
prior community service, language skills, and other rel-
evant factors. We should be concerned that highly qual-
ified minority applicants may perceive themselves to be
unwelcome at institutions that scale back their commit-
ment to diversity, particularly institutions that have
historically admitted few members of minority groups.
Medical schools should work hard to counter such
perceptions. Adequate financial-aid programs are im-
portant. Targeted financial incentives for practicing phy-





 Large managed-care firms are likely to provide
care for an increasing number of minority patients, in-
cluding Medicaid patients. Such firms should use some
of their ample financial resources to support efforts to
increase the number of minority physicians. In the long
run, universal health insurance, although it is not cur-





 Regardless of the fate of affirmative-
action programs in medicine, the social problems they
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THE POLITICS OF HUMAN-EMBRYO 







 late January 1996, President Bill Clinton signed a
continuing resolution to keep the government open.
Among other things, the resolution prohibits the use of





prohibition, which continues until September 30, the
end of the current fiscal year, would become permanent




Compromise language to limit the prohibition to em-
bryos created expressly for research purposes, but per-
mitting federally funded research on “spare” embryos





 A much stronger case can be made for
using spare embryos in research than for creating em-
bryos specifically for that purpose. We think that if this
case is made, the compromise language has a reason-
able chance of success, should Congress reconsider the
issue.
Compromise, however, requires disentangling the
subject of research on embryos from the continuing de-
bate on abortion. This is so because abortion is a defin-
ing political issue, and neither the Supreme Court’s










 nor the election of
President Clinton has dethroned it. But abortion is
about more than politics; it is fundamentally about eth-
ics, morals, equality, and religion, and how we think
about abortion reveals much about how we are likely to
think about other life-and-death issues in contemporary
American medical practice. Because politics as current-
ly practiced seems so unprincipled, there have been spo-
radic attempts to redefine abortion-related issues as
ethical questions and to set up national panels and ad-
visory groups to examine various practices and make
recommendations about their ethics. When the subjects
studied by such panels have been unrelated to abortion,
the panels have often helped to forge a consensus. But
when abortion has dominated the agenda, virtually no
progress has been made.
Even though the abortion debate in the United States
is not likely to be resolved by ethical argument, it
should not be permitted to hold every related issue
of medical ethics hostage, as it now does. Crucial is-
sues such as human-embryo research, prenatal genetic
screening, and the manipulation of embryos before
their implantation must be disengaged from the abor-
tion issue to receive the public debate they require.
This task is extremely complex, as the experience of
the Human Embryo Research Panel of the National In-
stitutes of Health (NIH) shows. It has been more than
18 months since the panel’s report was presented to the
director of the NIH, and it is unlikely that the director
will act on it until the political climate changes substan-
tially. Understanding the content and reasoning of this
report is critically important to efforts to end the ethi-























The Human Embryo Research Panel was created to
recommend guidelines for the funding of research on
embryos. It met six times from February to September





narrow charge was to classify potential research involv-
ing ex utero human embryos into one of three catego-
ries: research acceptable for federal funding, research
warranting additional review, and research unaccept-
able for federal funding.
By majority vote, the 11 researchers and 8 nonre-
searchers on the panel (a total of 10 men and 9 women)
concluded that research on methods of improving the
chances of pregnancy; fertilization; egg activation, mat-
uration, and freezing; genetic diagnosis before implan-
tation; and the development of embryonic stem cells




 Research on the
cloning and use of oocytes without their transfer to the
uterus for gestation was considered to warrant addition-
al review. Unacceptable research included the cloning





The panel offered specific guidelines for the review
and conduct of federally funded research. The guide-
lines stipulated that there be a qualified researcher and
a valid research design promising major scientific or
clinical benefit; that the research goals not be accom-
plishable with animals or gametes; that the number of
embryos required for the research be kept to the mini-
mum necessary to ensure valid results; that informed
consent be obtained from gamete donors; that no gam-
etes or embryos be purchased or sold for use in re-
search; that the research protocol be reviewed by an
institutional review board; that gamete donors be se-
lected equitably; and that no research be conducted on




The composition of panels such as this one has been
widely criticized. For example, an earlier NIH panel on
the use of fetal tissue for transplantation research was
criticized by right-to-life groups for including too few
members with explicitly right-to-life views. Others have
said that the Human Embryo Research Panel and ear-
lier panels had too many scientists as members. Femi-
nists have also complained that past embryo-research
panels, such as the Ethics Advisory Board, were made
up almost exclusively of men and had a tendency to
view “embryos and fetuses . . . as a man’s sperm per-
sonified [making them] appear to be real to these men




 The Human Embryo Re-
search Panel was balanced according to sex, but none-
theless there may have been insufficient attention to the
vast differences involved in supplying sperm as com-
pared with ova.
The reason the panel’s recommendations have been
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more or less ignored has little to do with its generally
reasonable conclusions. Rather, in our view, it is be-
cause the panel did not make a persuasive moral case
for the conclusions. Unless a strong moral framework is
presented that recognizes and addresses the concern of
those troubled by the use of human embryos for re-
search, such research is unlikely to gain the political ac-






























The panel members considered and rejected the view
that a human embryo has rights that completely pro-
hibit its use in research. To those who argue that an
embryo is a human being from the moment of concep-
tion, the panel responded that no single trait or prop-
erty is present at conception that suffices to confer per-
sonhood, and thus rights, on the embryo. This view is
persuasive. All human life begins at conception, but
many embryos do not implant, and even among those
that do, many spontaneously abort. Whatever shifts oc-
cur in the moral equation at conception, it is not self-
evident that that biologic event is of such moral impor-
tance that it should cause all human embryos to be
placed outside the realm of research.
Having rejected the idea of innate rights as the
framework for determining the moral status of the hu-





 Embryos, it said, possess “a va-
riety of distinct, intersecting and mutually supporting
considerations,” such as “genetic uniqueness, potential-
ity for full development, sentience, brain activity, and
degree of cognitive development.” Furthermore, “their
developing presence in an entity increases its moral sta-





 For those uncertain about the moral status
of human embryos, this was an unsuccessful effort to
please everyone.
Unfortunately, the pluralistic framework — in which
embryos possess a set of properties that somehow,
when mixed in an unexplained and mysterious way,
confer moral standing — is not convincing. This is pri-
marily so because that framework requires a detailed
analysis that explains why the particular properties cit-
ed confer moral worth, or to what degree each prop-
erty cited is necessary or sufficient. Without such an
underlying rationale, the framework looks like an at-
tempt to rationalize a desired conclusion — namely,
that some research on embryos ought to be permitted
— rather than to derive a conclusion from an ethical
analysis.
Such an analysis is needed in order to show that hav-
ing a unique genetic identity, a nervous system, a hu-
man appearance, the potential to become an adult,
brain activity, or the ability to feel pain moves an em-
bryonic entity over the line from being “deserving of re-
spect” to having moral standing such that experimen-
tation would violate its intrinsic rights. Many inanimate
objects, such as cadavers, works of art, national parks,
and archeological treasures, have moral standing, and
duties of respect are accorded to them in both law and
ethics, but they lack the biologic properties mentioned
by the panel. Likewise, many forms of animate life —
among them, dogs, rodents, pigs, goats, and primates
— are routinely used for research, but they would not
be considered acceptable subjects for experimentation
if the panel’s standards of moral worth were applied to
them. Without knowing why certain properties count,
we cannot draw clear boundaries between acceptable
and unacceptable types of research. From a pluralistic
perspective, we cannot tell whether it is right to prohib-
it research after the primitive streak appears at 14 days’
development. Why should research on older embryos
not be allowed, if it would benefit other embryos, fetus-
es, children, or adults?
Inability to define the moral status of the embryo
convincingly is the crucial failure of both the panel’s re-
port and the overall debate on the subject. Until it is
demonstrated that embryos are owed moral consider-
ation, concern about the ethics of research on embryos





 However, such curt dismissals completely
fail to respond to the deep moral reservations about
such research held by many Americans, including the
President. By adopting a bald political compromise on
a moral issue, the panel guaranteed that its report




CREATING EMBRYOS FOR RESEARCH
The need for a moral argument is most vividly dem-
onstrated by the question of whether to allow embryos
to be created solely for research. A recommendation in
favor of this idea was publicly rejected by President
Clinton in December 1994 and probably eroded what-
ever public support the report might otherwise have re-
ceived.8 As subsequent congressional action has clearly
indicated, anyone who recommends federal funding for
research on embryos has the burden of persuasion.1,2
We believe a persuasive moral argument for conduct-
ing some research on human embryos can be made.
Such an argument must explicitly and straightforward-
ly account for the relationships involved in human pro-
creation and its social context. An embryo has moral
standing not so much for what it is (at conception or
later), but because it is the result of procreative activity.
The strong public reaction to the ongoing embryo scan-
dal at the University of California at Irvine, for exam-
ple, occurred not because embryos were made the ob-
jects of medical research, but because they were used
to create babies without either the consent of the ova
providers or disclosure of information about the origins
of the children to the parents now raising them.9 People
have a direct interest in the status and fate of every em-
bryo formed from their gametes, because such embryos
carry their genes and can potentially become their chil-
dren. In this respect, the embryo is not only a symbol;
it is real. Similarly, society has a direct interest in that
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embryo, since society has an interest in how its mem-
bers procreate and how families are created.
Recognizing that the embryo’s moral status derives
not only from a property or cluster of properties it pos-
sesses, but also from the interests that potential parents
and society bring to procreation and reproduction,
makes it clearer why creating embryos solely for re-
search purposes is morally problematic. If two people
seek to have a child and create a number of embryos
to help them do so, there can be no doubt that they
hope that at least one of those embryos will become a
child. For most people it is the intention to create a
child that makes the creation of an embryo a moral act.
To create embryos solely for research — or to sell
them, or to use them in toxicity testing — seems mor-
ally wrong because it seems to cheapen the act of pro-
creation and turn embryos into commodities. Creating
embryos specifically for research also puts women at
risk as sources of ova for projects that provide them no
benefit.10
Careless use of language can also undercut moral
arguments. The panel, for example, described a hu-
man embryo as “significantly smaller than the period
at the end of this sentence.”4 These words suggest that
we should judge an embryo’s value by its size; that it
is, after all, just a speck or dot.11 But describing the pe-
riod as located “at the end of this sentence” suggests
that periods have value only in relation to words. Pe-
riods are related to sentences and conclude them. In
the same way, embryos are valued because of their re-
lationship to the gamete providers, the potential par-
ents, not because of their size. Deliberately creating
embryos that are disconnected from human relation-
ships takes them out of context. Removing them from
the context of human procreation calls for a much bet-
ter justification than the acquisition of potentially im-
portant information. Embryos created for procreation,
but ultimately not needed because the procreative
aims of the couple have been reached, do not have this
“manufactured-orphan” status. This argument paral-
lels one used by those who approve of using tissue
from aborted fetuses for research, but many of these
same people would be horrified at the idea that a
woman could become pregnant for the sole purpose of
having an abortion to produce fetal tissue for research
purposes.
Thus, many people, like President Clinton, could ap-
prove of research using “spare” embryos created by in
vitro fertilization without approving of the creating of
embryos for that specific purpose.2,8 Provided with rea-
sonable grounds for distinguishing research on spare
embryos from research on embryos created solely for
the purpose, even the Republican-dominated House of
Representatives might have made the distinction. The
House Appropriations Committee, for example, voted
30 to 23 in July 1995 to bar all federal funding for re-
search on human embryos.12 A proposed amendment to
permit such funding for research on spare embryos
failed by a tie vote (26–26). It seems plausible that a
more nuanced rationale for this distinction could have
persuaded at least 1 of the 26 members who voted
against the amendment to vote for it.
The moral problem with making embryos for re-
search is that as a society we do not want to see em-
bryos treated as products or as mere objects, for fear
that we will cheapen the value of parenting, risk com-
mercializing procreation, and trivialize the act of pro-
creation. It is society’s moral attitude toward procre-
ation and the interests of those whose gametes are
involved in making the embryos that provide the moral
force behind the restriction or prohibition of the man-
ufacture of embryos for nonprocreative uses. A moral
framework that reduces the matter to an exclusive fo-
cus on the intrinsic properties of embryos, ignoring the
interests of those whose gametes make the embryos
and the circumstances under which procreation occurs,
cannot persuade, or even engage, those to whom the
creation of embryos solely for research is morally sus-
pect. Obtaining consent is not enough. A new frame-
work — one that takes relationships seriously — is es-
sential.
THE POLITICS OF ABORTION
An ethical discussion of research on embryos ex utero
need not involve abortion, because no pregnancy is in-
volved. When legally protectable human life begins is
an important issue, but it is one that must be confront-
ed on its own terms. Moreover, embryo research itself
can actually help both to increase the number of preg-
nancies and to reduce the number of abortions. One
example is preimplantation genetic diagnosis, which
involves the extracorporeal creation of an embryo
through in vitro fertilization, followed by blastomere
removal for genetic diagnosis. Only embryos deter-
mined not to be affected by the genetic disorder in
question are then transferred to the uterus.13 Such ge-
netic diagnosis, unlike conventional prenatal diagnosis
(chorionic-villus sampling or amniocentesis), obviates
the need for a woman to decide whether to undergo an
abortion.
A strong case can also be made for the importance
of embryo studies to understanding basic problems of
fertilization and development and improving the effec-
tiveness of in vitro fertilization itself. Research on fetal-
tissue transplantation did not garner public support
and federal financing until supporters persuaded Con-
gress that it might benefit the treatment of major dis-
eases, such as Parkinson’s disease.14 Embryo research
will not receive needed support unless it is linked more
directly to research on fertility. It should be acknowl-
edged, of course, that even those to whom choosing
among “permanent storage,” destruction, and donation
presents no particular ethical problem may nonetheless
reject the idea of research using spare embryos on the
prudential basis that once such research is accepted, re-
search on embryos created specifically for research is
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inevitable. It is easy to see the force of this version of
the slippery-slope argument,10 but a line can nonethe-
less be drawn and maintained as long as the rationale
for it is accepted and embryo research addresses ques-
tions directly related to infertility.
The country needs clear and consistent rules for re-
search on human embryos, as well as uniform methods
of review. This uniformity cannot be provided by local
institutional review boards, but only by a central review
panel. There is a compelling need for the nationwide
regulation of embryo research, and federal funding of
such research would provide an impetus for such uni-
form rules.3
Ethics in the public sector cannot transcend politics
completely, because the public sector is the political are-
na. But for ethical guidelines to survive changes in polit-
ical power in Washington, they must be grounded on
more than political expediency. When politicians can as-
sociate issues of medical ethics with the politics of abor-
tion, they will do so. In politics, the majority vote wins.
In ethics, however, ethical reasoning should prevail: a
vote without a supporting rationale will not be convinc-
ing to policy makers in a world where one’s position on
abortion can directly affect one’s political future.
Ethics panels debating an abortion-related issue must
persuasively distinguish their subject from abortion it-
self and provide a strong ethical reason for the research
and its need for public funding. As the angry response
to President Clinton’s April 10 veto of a ban on “par-
tial-birth” abortion demonstrates, we are nowhere near
a political consensus about abortion.15,16 Unless we are
content to let the politics of abortion bring discussions
of publicly funded medical research to gridlock, we must
do much better at articulating an ethical basis for abor-
tion-related research.
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